Brief: Heat Biologics Reports Qtrly Loss Per Share of $0.17

Scorpius Holdings

15/05/2019 16:06

May 15 (Reuters) - Heat Biologics Inc  HTBX.O :
    * HEAT BIOLOGICS INC - ON TRACK TO COMPLETE ENROLLMENT OF
PHASE 2
LUNG CANCER TRIAL IN Q2 2019 AND REPORT ADDITIONAL INTERIM DATA
IN Q4 2019
    * HEAT BIOLOGICS INC - ANTICIPATES RECEIVING ADDITIONAL $6.9
MILLION IN GRANT FUNDS AFTER FILING PTX-35 IND
    * HEAT BIOLOGICS INC - QTRLY LOSS PER SHARE $0.17
    * HEAT BIOLOGICS INC - ENDED QUARTER WITH APPROXIMATELY
$23.5
MILLION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS.

Source text: (https://bit.ly/2HE9o8z)
Further company coverage:  HTBX.O 

 ((Reuters.Briefs@thomsonreuters.com;))